Vaccine adjuvant discovery program
Award Notice Posted
- Solicitation number
- BAA-NIAID-75N93022R00022
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N9302400023
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Chicago Illinois 60637 USA
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases, a civilian agency under the Department of Health and Human Services, has awarded a cost-reimbursement contract worth $9,807,060 to the University of Chicago for the Vaccine Adjuvant Discovery Program. The contract is not fixed-priced and does not have a set-aside. The award was posted on September 20, 2024 and made on September 19, 2024.
Notice text
This is not fixed-priced. This is a cost-reimbursement contract.
Awarded contract 75N9302400023 to UNIVERSITY OF CHICAGO for 9807060.00 on 2024-09-19.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Vaccine adjuvant discovery program | Award Notice | |
| This notice | Award Notice | |
| Vaccine adjuvant discovery program | Award Notice | |
| Vaccine adjuvant discovery program | Award Notice | |
| Vaccine adjuvant discovery program | Solicitation | |
| Vaccine adjuvant discovery program | Pre-Solicitation |
6 of 7 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity